Objective(s): To examine the role of asthma as an effect modifier of the association between adverse birth outcomes and neurodevelopmental disabilities (NDDs) with an emphasis on race/ethnicity. Study designData were collected through the National Survey of Children’s Health. This cross-sectional study included 131, 774 children aged 0-17 years. Study exposures comprised of adverse birth outcomes including preterm birth and low birth weight. Weighted prevalence estimates and odds ratios with 95% confidence intervals among children with and without adverse birth outcomes were calculated for NDDs including attention-deficit/hyperactivity disorder, autism spectrum disorder, cerebral palsy, seizure, and several other including behavior problems. Adjusted odds ratios were stratified by asthma status and separate interactions were assessed for each outcome. ResultsOf 131,774 participants, 10,227 were born low birth weight (9.12%; 95% CI: 8.77%-9.49%), 14,058 were born preterm (11.35%; 95% CI: 10.94%-11.76%), and 16,166 participants had asthma (11.97%; 95% CI: 11.58%-12.37%). There were 68,100 males (51.11%), 63,674 females (48.89%), 102,061 non-Hispanic whites (NHW) (66.92%), 8,672 non-Hispanic blacks (NHB) (13.97%), and 21,041 participants (19.11%) categorized as Other. NHB children with adverse birth outcomes had higher prevalence of several NDDs compared to NHW children. Conclusion(s): Asthma was not shown to be an effect modifier of the association between adverse birth outcomes and NDDs. Nevertheless, these results suggest that NDDs are more prevalent within US children with adverse birth outcomes. We also see similar trends where NHB children with adverse birth outcomes have higher prevalence of NDDs compared to NHW children. These findings support screening for NDDs in pediatric health care settings among patients with adverse birth outcomes, particularly among those from ethnic minority backgrounds.